MAIA Biotechnology Inc
MAIA
MAIA Biotechnology Inc AI Insights
Informational only. Not investment advice.Snapshot
- Zero revenue pre-clinical biotech burning 15.7M FCF TTM with only 10.9M cash - under 9 months runway at current burn rate.[Cash and Equivalents]
- Equity nearly wiped: 41.7K book value vs 11.7M liabilities. P/B of 956x reflects pure option value on pipeline.[Common Stockholders Equity]
- R&D of 15.6M TTM is 63% of total opex - focused spend, but no revenue to fund it.[Research and Development]
Watch Triggers
- Cash and Equivalents: Falls below 6M — Would signal imminent financing at likely distressed terms
- Shares Outstanding: Increases >20% in single quarter — Confirms dilutive raise - watch for terms and use of proceeds
- Research and Development: Drops below 10M annualized — Would indicate pipeline slowdown or cash conservation mode
Bull Case
39.8M market cap on pre-revenue biotech offers asymmetric upside if clinical trials succeed. EV of 29M is modest for any viable oncology asset.
R&D-focused burn (63% of opex) suggests capital efficiency vs peers. Working capital positive at 1.8M provides short-term buffer.
Bear Case
Sub-9-month cash runway with zero revenue guarantees dilution. Current 33.2M shares could double or triple on next raise.
Book value of 41.7K vs 11.7M liabilities means equity is effectively zero. Any setback triggers existential risk.
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage MAIA's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Dilutive financing within 6-9 months is near-certain given cash runway constraints.
- 10.9M cash vs 15.7M annual burn
- Already raised 3.8M via stock issuance TTM
- No debt capacity with 41.7K equity
Valuation Context
Caveats
Public Strategies Rankings
See how MAIA Biotechnology Inc ranks across different investment strategies.
Leverage MAIA's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.
MAIA Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$64.41M | — | ||
$53.52M | — | ||
0.00 | — | ||
$0 | — | ||
$-0.82 | — | ||
0% | 0.0% | — | |
0% | 0.0% | — | |
$-15.73M | — | ||
-27 | -1502.9% | — | |
Beta 5Y (Monthly) | unknown | — |
MAIA Dividend History
MAIA Stock Splits
MAIA SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
11/07/25 | 09/30/25 | 10-Q | |
08/11/25 | 06/30/25 | 10-Q | |
05/09/25 | 03/31/25 | 10-Q | |
03/21/25 | 12/31/24 | 10-K | |
11/12/24 | 09/30/24 | 10-Q | |
08/09/24 | 06/30/24 | 10-Q | |
05/14/24 | 03/31/24 | 10-Q | |
03/21/24 | 12/31/23 | 10-K | |
11/07/23 | 09/30/23 | 10-Q | |
08/08/23 | 06/30/23 | 10-Q | |
05/08/23 | 03/31/23 | 10-Q | |
03/24/23 | 12/31/22 | 10-K | |
11/09/22 | 09/30/22 | 10-Q | |
08/22/22 | 06/30/22 | 10-Q | |
07/29/22 | 03/31/22 | 424B4 | |
07/29/22 | 12/31/21 | 424B4 | |
02/06/23 | 09/30/21 | 10-Q/A | |
08/22/22 | 06/30/21 | 10-Q | |
07/29/22 | 03/31/21 | 424B4 |